Survivin T9809C, an SNP located in 3′-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Hsieh, Yih Shou ^a,b   Tsai, Chiung Man ^c   Yeh, Chao Bin ^a,b   Yang, Shun Fa ^a,b   Hsieh, Yi Hsien ^a   Weng, Chia Jui ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Hualien Hospital   (Taiwan)

^d TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENOTYPE; HOMOZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WILD TYPE;

AGED; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TAIWAN; TERMINAL REPEAT SEQUENCES;

EID: 84859063653     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2123-3     Document Type: Article

References (44)

1. DC Altieri 2003 Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 8581 8589 14634620 10.1038/sj.onc.1207113 1:CAS:528:DC%2BD3sXptFOmtbY%3D
2. G Ambrosini C Adida G Sirugo DC Altieri 1998 Induction of apoptosis and inhibition of cell proliferation by BIRC5 gene targeting J Biol Chem 273 11177 11182 9556606 10.1074/jbc.273.18.11177 1:CAS:528:DyaK1cXjtFGrsr4%3D
3. L Yang H Zhu B Zhou H Gu H Yan N Tang, et al. 2009 The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population Dig Dis Sci 54 1021 1028 18716870 10.1007/s10620-008-0441-5 1:CAS:528:DC%2BD1MXjvVWjtLg%3D
4. K Kawamura N Sato J Fukuda H Kodama J Kumagai H Tanikawa, et al. 2003 Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos Dev. Biol 256 331 341 12679106 10.1016/S0012-1606(02) 00135-5 1:CAS:528:DC%2BD3sXisFWmsb8%3D
5. GS Salvesen CS Duckett 2002 IAP proteins: blocking the road to death's door Nat Rev Mol Cell Biol 3 401 410 12042762 10.1038/nrm830 1:CAS:528:DC%2BD38XltlartL4%3D
6. DC Altieri 2001 The molecular basis and potential role of survivin in cancer diagnosis and therapy Trends Mol Med 7 542 547 11733216 10.1016/S1471-4914(01)02243-2 1:CAS:528:DC%2BD3MXovVCnu70%3D
7. MJ Duffy N O'Donovan DJ Brennan WM Gallagher BM Ryan 2007 Survivin: a promising tumor biomarker Cancer Lett 249 49 60 17275177 10.1016/j.canlet.2006. 12.020 1:CAS:528:DC%2BD2sXjsVekt7Y%3D
8. SF Shariat R Ashfaq PI Karakiewicz O Saeedi AI Sagalowsky Y Lotan 2007 Survivin expression is associated with bladder cancer presence, stage, progression, and mortality Cancer 109 1106 1113 17311310 10.1002/cncr.22521 1:CAS:528:DC%2BD2sXkt1Wmt7Y%3D
9. BS Shastry 2002 SNP alleles in human disease and evolution J Hum Genet 47 561 566 12436191 10.1007/s100380200086 1:CAS:528:DC%2BD38XoslOru78%3D
10. CJ Weng YH Hsieh CM Tsai YH Chu KC Ueng YF Liu, et al. 2010 Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma Ann Surg Oncol 17 1808 1815 20119675 10.1245/s10434-009-0904-8
11. PA Farazi RA DePinho 2006 Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 674 687 16929323 10.1038/nrc1934 1:CAS:528:DC%2BD28XosVOmsLs%3D
12. Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematol Am Soc Hematol Educ Program. 2006;375-80.
13. Y Yano F Yamashita K Kuwaki K Fukumori O Kato H Yamamoto, et al. 2006 Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II Liver Int 26 789 795 16911460 10.1111/j.1478-3231.2006. 01310.x 1:CAS:528:DC%2BD28XhtVegsrvL
14. MA Feitelson 2006 Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma Cancer Lett 239 10 20 16154256 10.1016/j.canlet.2005.07.009 1:CAS:528:DC%2BD28Xms1agtrs%3D
15. CJ Weng CM Tsai YC Chen YH Hsieh CW Lin YF Liu, et al. 2010 Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma Ann Surg Oncol 17 3394 3401 20706793 10.1245/s10434-010-1124-y
16. TY Chen YC Li YF Liu CM Tsai YH Hsieh CW Lin, et al. 2011 Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma Ann Surg Oncol 18 2348 2356 21298348 10.1245/s10434-011-1574-x
17. SS Thorgeirsson JW Grisham 2002 Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 339 346 12149612 10.1038/ng0802-339 1:CAS:528:DC%2BD38Xls1Oku7c%3D
18. C Adida PL Crotty J McGrath D Berrebi J Diebold DC Altieri 1998 Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation Am J Pathol 152 43 49 9422522 1:CAS:528:DyaK1cXktlygtA%3D%3D
19. R Gianani E Jarboe D Orlicky M Frost J Bobak R Lehner, et al. 2001 Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa Hum Pathol 32 119 125 11172305 10.1053/hupa.2001.21897 1:CAS:528: DC%2BD3MXjslKmtbs%3D
20. M Falleni C Pellegrini A Marchetti B Oprandi F Buttitta F Barassi, et al. 2003 Survivin gene expression in early-stage nonsmall cell lung cancer J Pathol 200 620 626 12898598 10.1002/path.1388 1:CAS:528:DC%2BD3sXntl2nurk%3D
21. CJ Chen MW Yu YF Liaw 1997 Epidemiological characteristics and risk factors of hepatocellular carcinoma J Gastroenterol Hepatol 12 S294 S308 9407350 10.1111/j.1440-1746.1997.tb00513.x 1:STN:280:DyaK1c%2FntFansw%3D%3D
22. TH Chen CJ Chen MF Yen SN Lu CA Sun GT Huang, et al. 2002 Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan Int J Cancer 98 257 261 11857416 10.1002/ijc.10122 1:CAS:528:DC%2BD38XhsVSkuro%3D
23. MC Tsai KM Kee YD Chen LC Lin LS Tsai HH Chen, et al. 2007 Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan J Gastroenterol Hepatol 22 92 98 17201888 10.1111/j.1440-1746.2006.04489.x
24. H Akkiz S Bayram A Bekar B Ozdil E Akgöllü AT Sümbül, et al. 2009 G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study Cancer Epidemiol 33 261 264 19683483 10.1016/j.canep.2009.06.001 1:CAS:528: DC%2BD1MXhsFKjs7zP
25. CC Chang SC Chen YH Hsieh YC Chen TY Chen YH Chu, et al. 2009 Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma Clin Chem Lab Med 47 412 418 19327121 10.1515/CCLM.2009.092 1:CAS:528: DC%2BD1MXlvVGgsLk%3D
26. MA Buendia 2000 Genetics of hepatocellular carcinoma Semin Cancer Biol 10 185 200 10936068 10.1006/scbi.2000.0319 1:STN:280:DC%2BD3M%2Fjtlyruw%3D%3D
27. ZJ Cheng LH Hu SJ Huang 2008 Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma Ai Zheng 27 258 263 18334114 1:CAS:528:DC%2BD1MXjtFWktbc%3D
28. JS Jang KM Kim KH Kang JE Choi WK Lee CH Kim, et al. 2008 Polymorphisms in the survivin gene and the risk of lung cancer Lung Cancer 60 31 39 17961802 10.1016/j.lungcan.2007.09.008
29. M Gazouli N Tzanakis G Rallis G Theodoropoulos I Papaconstantinou A Kostakis, et al. 2009 Survivin -31G/C promoter polymorphism and sporadic colorectal cancer Int J Colorectal Dis 24 145 150 18946675 10.1007/s00384-008- 0601-2
30. Y Xu F Fang G Ludewig G Jones D Jones 2004 A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells DNA Cell Biol 23 527 537 15383173 1:CAS:528: DC%2BD2cXns1ersro%3D
31. CH Han Q Wei KK Lu Z Liu GB Mills LE Wang 2009 Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer Int J Clin Exp Med 2 289 299 20057973 1:CAS:528:DC%2BD1MXhsVOgur3L
32. AA Borbely M Murvai K Szarka J Konya L Gergely Z Hernadi G Veress 2007 Survivin promoter polymorphism and cervical carcinogenesis J Clin Pathol 60 303 306 16714396 10.1136/jcp.2006.037804 1:CAS:528:DC%2BD2sXktlOrtr0%3D
33. X Yang G Xiong X Chen X Xu K Wang Y Fu, et al. 2009 Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma J Cancer Res Clin Oncol 135 1341 1349 19352701 10.1007/s00432-009-0575-7 1:CAS:528:DC%2BD1MXhtVSitL7K
34. R Boidot F Vegran D Jacob S Chevrier N Gangneux J Taboureau, et al. 2008 The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas Gene Chromosomes Cancer 47 299 308 10.1002/gcc.20533 1:CAS:528:DC%2BD1cXivFers7Y%3D
35. R Boidot F Végran D Jacob S Chevrier M Cadouot O Feron, et al. 2010 The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism Oncogene 29 2577 2584 20101202 10.1038/onc.2009.525 1:CAS:528:DC%2BC3cXltl2mtbo%3D
36. WH Majoros U Ohler 2007 Spatial preferences of microRNA targets in 3′ untranslated regions BMC Genomics 8 152 17555584 10.1186/1471-2164-8- 152
37. F Vegran R Boidot C Oudin JM Riedinger S Lizard-Nacol 2005 Distinct expression of Survivin splice variants in breast carcinomas Int J Oncol 27 1151 1157 16142334 1:CAS:528:DC%2BD2MXhtFeisrvI
38. AG Antonacopoulou K Floratou V Bravou A Kottorou FI Dimitrakopoulos S Marousi, et al. 2010 The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival Anal Cell Pathol (Amst) 33 177 189 1:CAS:528:DC%2BC3MXovVymsQ%3D%3D
39. W Saitoh T Sakamoto AE Hegab A Nomura Y Ishii Y Morishima, et al. 2006 MMP14 gene polymorphisms in chronic obstructive pulmonary disease Int J Mol Med 17 621 626 16525718 1:CAS:528:DC%2BD28XjsVyisb8%3D
40. KB Schwarz 1996 Oxidative stress during viral infection: a review Free Radical Biol Med 21 641 649 10.1016/0891-5849(96)00131-1 1:CAS:528: DyaK28Xmt12lsbc%3D
41. A Mansouri B Fromenty A Berson MA Robin S Grimbert M Beaugrand, et al. 1997 Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients J Hepatol 27 96 102 9252080 10.1016/S0168-8278(97) 80286-3 1:CAS:528:DyaK2sXltVOrs7c%3D
42. I Merican R Guan D Amarapuka MJ Alexander A Chutaputti RN Chien, et al. 2000 Chronic hepatitis B virus infection in Asian countries J Gastroenterol Hepatol 15 1356 1361 11197043 10.1046/j.1440-1746.2000.0150121356.x 1:STN:280:DC%2BD3M7jvFCitw%3D%3D
43. D Lavanchy 2004 Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepatitis 11 97 107 10.1046/j.1365-2893.2003.00487.x 1:STN:280: DC%2BD2c7gs1Whug%3D%3D
44. BE Wang WM Ma A Sulaiman S Noer S Sumoharjo D Sumarsidi, et al. 2002 Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries J Med Virol 67 394 400 12116033 10.1002/jmv.10087